Chronic Beneficial Effects of Type 1 Angiotensin II Receptor Antagonist in Patients with Chronic Hypoxemic Pulmonary Diseases

Publisher： Karger

E-ISSN： 1421-9751|97|2|111-112

ISSN： 0008-6312

Source： Cardiology, Vol.97, Iss.2, 2002-04, pp. : 111-112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of Angiotensin II Type 1 Receptor Blocker on Blood Pressure Variability and Cardiovascular Remodeling in Hypertensive Patients on Chronic Peritoneal Dialysis

By  

Nephron Clin Pract, Vol. 112, Iss. 1, 2009-04 ,pp. : c31-c40

Karger

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Antagonist as an Angiogenic Inhibitor in Urogenital Cancer

By  

Reviews on Recent Clinical Trials, Vol. 4, Iss. 2, 2009-05 ,pp. : 75-78

Bentham Science Publishers

Access to resources Recommend Favorite

Protective effects of the angiotensin type 1 receptor antagonist losartan in infection‐induced and arthritis‐associated alveolar bone loss

By  

JOURNAL OF PERIODONTAL RESEARCH, Vol. 50, Iss. 6, 2015-12 ,pp. : 814-823

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis

By  

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 7, 2015-07 ,pp. : 722-728

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment

By  

Nephron Clin Pract, Vol. 121, Iss. 1-2, 2012-10 ,pp. : c73-c82

Karger

Access to resources Recommend Favorite